Advertisement
UK markets open in 4 hours 51 minutes

  • NIKKEI 225

    38,844.78
    +227.68 (+0.59%)
     

  • HANG SENG

    18,909.99
    -285.61 (-1.49%)
     

  • CRUDE OIL

    76.93
    -0.64 (-0.83%)
     

  • GOLD FUTURES

    2,375.10
    -17.80 (-0.74%)
     

  • DOW

    39,671.04
    -201.95 (-0.51%)
     

  • Bitcoin GBP

    54,627.74
    -575.14 (-1.04%)
     

  • CMC Crypto 200

    1,511.59
    -14.83 (-0.97%)
     

  • NASDAQ Composite

    16,801.54
    -31.08 (-0.18%)
     

  • UK FTSE All Share

    4,560.55
    -23.85 (-0.52%)
     
Money:

How to protect your finances during divorce

However you do it divorce will leave you poorer, and you will need to watch your finances carefully

CareDx (CDNA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2-min read

For the quarter ended March 2024, CareDx (CDNA) reported revenue of $72.05 million, down 6.7% over the same period last year. EPS came in at -$0.03, compared to -$0.11 in the year-ago quarter.

The reported revenue represents a surprise of +13.24% over the Zacks Consensus Estimate of $63.63 million. With the consensus EPS estimate being -$0.19, the EPS surprise was +84.21%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how CareDx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Patient and digital solutions: $9.62 million compared to the $9.64 million average estimate based on two analysts. The reported number represents a change of +11.6% year over year.

  • Revenue- Testing services: $53.84 million versus the two-analyst average estimate of $46.42 million. The reported number represents a year-over-year change of -12.9%.

  • Revenue- Product: $8.59 million versus the two-analyst average estimate of $7.39 million. The reported number represents a year-over-year change of +25.3%.

View all Key Company Metrics for CareDx here>>>

Shares of CareDx have returned +9.9% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CareDx, Inc. (CDNA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research